Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Endosomal signaling and a novel pathway defined by the natural killer receptor KIR2DL4 (CD158d).

Rajagopalan S.

Traffic. 2010 Nov;11(11):1381-90. doi: 10.1111/j.1600-0854.2010.01112.x. Epub 2010 Sep 20. Review.

2.

DNA-PKcs controls an endosomal signaling pathway for a proinflammatory response by natural killer cells.

Rajagopalan S, Moyle MW, Joosten I, Long EO.

Sci Signal. 2010 Feb 23;3(110):ra14. doi: 10.1126/scisignal.2000467.

3.

TNFR-associated factor 6 and TGF-β-activated kinase 1 control signals for a senescence response by an endosomal NK cell receptor.

Rajagopalan S, Lee EC, DuPrie ML, Long EO.

J Immunol. 2014 Jan 15;192(2):714-21. doi: 10.4049/jimmunol.1302384. Epub 2013 Dec 11.

4.

KIR2DL4 (CD158d): An activation receptor for HLA-G.

Rajagopalan S, Long EO.

Front Immunol. 2012 Aug 20;3:258. doi: 10.3389/fimmu.2012.00258. eCollection 2012.

5.

Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodeling.

Rajagopalan S, Long EO.

Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20596-601. doi: 10.1073/pnas.1208248109. Epub 2012 Nov 26.

6.

Activation of NK cells by an endocytosed receptor for soluble HLA-G.

Rajagopalan S, Bryceson YT, Kuppusamy SP, Geraghty DE, van der Meer A, Joosten I, Long EO.

PLoS Biol. 2006 Jan;4(1):e9.

7.

Genome-wide siRNA screen reveals a new cellular partner of NK cell receptor KIR2DL4: heparan sulfate directly modulates KIR2DL4-mediated responses.

Brusilovsky M, Cordoba M, Rosental B, Hershkovitz O, Andrake MD, Pecherskaya A, Einarson MB, Zhou Y, Braiman A, Campbell KS, Porgador A.

J Immunol. 2013 Nov 15;191(10):5256-67. doi: 10.4049/jimmunol.1302079. Epub 2013 Oct 14.

8.

KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential.

Faure M, Long EO.

J Immunol. 2002 Jun 15;168(12):6208-14.

9.

A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells.

Rajagopalan S, Long EO.

J Exp Med. 1999 Apr 5;189(7):1093-100. Erratum in: J Exp Med 2000 Jun 5;191(11):following 2027.

10.

Assessment of the Toll-like receptor 3 pathway in endosomal signaling.

Matsumoto M, Funami K, Tatematsu M, Azuma M, Seya T.

Methods Enzymol. 2014;535:149-65. doi: 10.1016/B978-0-12-397925-4.00010-9.

PMID:
24377923
11.

Ubiquitylation of an internalized killer cell Ig-like receptor by Triad3A disrupts sustained NF-κB signaling.

Miah SM, Purdy AK, Rodin NB, MacFarlane AW 4th, Oshinsky J, Alvarez-Arias DA, Campbell KS.

J Immunol. 2011 Mar 1;186(5):2959-69. doi: 10.4049/jimmunol.1000112. Epub 2011 Jan 26.

12.
13.
14.

Killer Ig-like receptor 2DL4 does not mediate NK cell IFN-γ responses to soluble HLA-G preparations.

Le Page ME, Goodridge JP, John E, Christiansen FT, Witt CS.

J Immunol. 2014 Jan 15;192(2):732-40. doi: 10.4049/jimmunol.1301748. Epub 2013 Dec 11.

16.

The genotype of the NK cell receptor, KIR2DL4, influences INFgamma secretion by decidual natural killer cells.

Goodridge JP, Lathbury LJ, John E, Charles AK, Christiansen FT, Witt CS.

Mol Hum Reprod. 2009 Aug;15(8):489-97. doi: 10.1093/molehr/gap039. Epub 2009 Jun 9.

PMID:
19509110
17.

The Killer Cell Ig-like Receptor 2DL4 Expression in Human Mast Cells and Its Potential Role in Breast Cancer Invasion.

Ueshima C, Kataoka TR, Hirata M, Furuhata A, Suzuki E, Toi M, Tsuruyama T, Okayama Y, Haga H.

Cancer Immunol Res. 2015 Aug;3(8):871-80. doi: 10.1158/2326-6066.CIR-14-0199. Epub 2015 Mar 3.

18.

A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2.

Sivori S, Falco M, Carlomagno S, Romeo E, Soldani C, Bensussan A, Viola A, Moretta L, Moretta A.

Blood. 2010 Sep 9;116(10):1637-47. doi: 10.1182/blood-2009-12-256586. Epub 2010 Feb 10.

19.

Endosomes: a legitimate platform for the signaling train.

Murphy JE, Padilla BE, Hasdemir B, Cottrell GS, Bunnett NW.

Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17615-22. doi: 10.1073/pnas.0906541106. Epub 2009 Oct 12. Review.

20.

Supplemental Content

Support Center